working group shall elect a cochair from among its members. (d) Duties The duties of the working group shall include the following: (1) To provide a forum for members of the working group to discuss issues involving access, threats, and vulnerabilities to pharmaceuticals, therapeutics and medical devices in operational environments of the Department. (2) To identify current vulnerabilities, including supply chain issues, active pharmaceutical ingredient supplies, device component issues and cyber and electronic threats that may disrupt operations of the Department. (3) To identify locations where the Secretary can support manufacturing capabilities needed to improve the timely increase of domestic production. (4) To review policies of the Department to identify pharmaceutical manufacturing and supply guidance related to— (A) diversification of the supply chain